Jane Street’s Sanara MedTech SMTI Stock Holding History

Jane Street’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$663K	Buy	38,584 +23,367	+154%	+$481K	﹤0.01%	7382
2025 Q4	$355K	Buy	+15,217	New	+$393K	﹤0.01%	8452
2023 Q2	–	Sell	-17,594	Closed	-$726K	–	9510
2023 Q1	$726K	Buy	+17,594	New	+$742K	﹤0.01%	5647

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jane Street's SMTI Position: Q1 2026 in Review

Jane Street increased its Sanara MedTech (SMTI) stake by 154% in Q1 2026, buying an estimated $481K and bringing the position to 38,584 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #7382.

Jane Street first reported a position in SMTI in Q1 2023 and has held it in 3 quarters since. The position peaked at $726K in Q1 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Jane Street held 38,584 shares of Sanara MedTech worth $663K as of Q1 2026.
Jane Street bought 23,367 Sanara MedTech shares in Q1 2026, an estimated $481K.
Sanara MedTech made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7382 holding.
Jane Street first reported a position in Sanara MedTech in Q1 2023 and has held it in 3 quarters since.
Jane Street's Sanara MedTech position peaked at $726K in Q1 2023.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.